Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 3: Special Issue on Influenza Vaccines, commemorating the 100th anniversary of Pandemic Flu
Submit an article Journal homepage
630
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults

Gulbanu SarsenbayevaLaboratory of Technology and Biopreparation Control, Research Institute for Biological Safety Problems, Gvardeysk, KazakhstanCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-1310-3936
ORCID Icon,
Yevgeniy VolginLaboratory of Technology and Biopreparation Control, Research Institute for Biological Safety Problems, Gvardeysk, Kazakhstan
,
Markhabat KassenovLaboratory of Technology and Biopreparation Control, Research Institute for Biological Safety Problems, Gvardeysk, Kazakhstan
,
Timur IssagulovLaboratory of Technology and Biopreparation Control, Research Institute for Biological Safety Problems, Gvardeysk, Kazakhstan
,
Nikolay BogdanovLaboratory of Technology and Biopreparation Control, Research Institute for Biological Safety Problems, Gvardeysk, Kazakhstan
,
Abylay SansyzbayLaboratory of Technology and Biopreparation Control, Research Institute for Biological Safety Problems, Gvardeysk, Kazakhstan
,
Marina StukovaVector Vaccine Laboratory, Influenza Research Institute, St. Petersburg, Russian Federation
,
Zhanna BuzitskayaVector Vaccine Laboratory, Influenza Research Institute, St. Petersburg, Russian Federation
,
Ilyas КulmagambetovCentre for Clinical Medicine and Research, Almaty, Kazakhstan
,
Timur DavlyatshinClinical Laboratory «T-Helper», Almaty, Kazakhstan
&
Berik KhairullinLaboratory of Technology and Biopreparation Control, Research Institute for Biological Safety Problems, Gvardeysk, Kazakhstan
 show all
Pages 609-614 | Received 07 Aug 2017, Accepted 28 Sep 2017, Published online: 12 Dec 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gulbanu Sarsenbayeva, Timur Issagulov, Markhabat Kassenov, Ruslan Abitay, Mukhit Orynbayev, Marina Stukova, Maria Pisareva, Timur Davlyatshin, Kutumbetov Lespek & Berik Khairullin. (2020) Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan. Human Vaccines & Immunotherapeutics 16:8, pages 1791-1797.
Read now
Susanna Esposito. (2018) 100 years since the 1918 influenza pandemic. Human Vaccines & Immunotherapeutics 14:3, pages 504-507.
Read now

Articles from other publishers (1)

Tosha Pandya, Prachi Joshi, Rudree Pathak & Shreeraj Shah. (2023) Nano-vaccination Strategies: Applications and Challenges for Intranasal Immunization. Current Pharmaceutical Biotechnology 24:8, pages 946-969.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.